The Effect of a Novel Nasal Airflow System on Sleep Quality & Perception

Comparison of nasal airflow via cannula vs nasal pressure via mask on sleep quality and perception in mild to moderate obstructive sleep apnoea

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12607000630415

Enrollment

Registered

2007-12-12

Start date

2007-12-15

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study is being conducted to determine the effect of a novel treatment for sleep apnoea, using a nasal airflow cannula to raise phayngeal pressure. The outcomes assessed will be objective measures of sleep quality, as well as patient assessment of sleep quality. The treatment will be compared to CPAP, which is the current standard treatment for sleep apnoea.

Interventions

Constant airflow administered via nasal cannual to deliver pharyngeal pressure <4 cm H20 for 8 hours during 1 night.

Study design

Allocation

Randomised controlled trial

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Healthy volunteers

Yes

Inclusion criteria

apnoea hypopnoea index <30

Exclusion criteria

Other acute or chronic respiratory illness including but not limited to: Chronic obstructive pulmonary disease & asthma

Outcome results